Sihuan Pharmaceutical Holdings Group Ltd

00460

Company Profile

  • Business description

    Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Respiratory, Neurology, and others. The group has three reportable segments: the medical aesthetic products segment including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others; the medicine and other medicine segments; and the generic medicine segment which generates key revenue. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the United States.

  • Contact

    Zhubang 2000
    22nd Floor, Building 4
    West Balizhuang, Chaoyang District
    Beijing100025
    CHN

    T: +86 1057693700

    https://www.sihuanpharm.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    2,767

Stocks News & Analysis

stocks

Alibaba fair value increases by 49%

Stronger-than-expected AI demand internationally and domestically.
stocks

Our fair value on ASX share falls by half

Downgrading our estimates due to lower growth.
stocks

A 5-Star US stock to buy with a near-5% yield

Undervalued by 23%, this cheap dividend stock is a top pick in its sector.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,148.5045.400.50%
CAC 407,883.9613.280.17%
DAX 4023,743.273.800.02%
Dow JONES (US)46,247.29299.970.65%
FTSE 1009,337.9053.070.57%
HKSE26,622.88494.681.89%
NASDAQ22,484.0799.370.44%
Nikkei 22545,043.75311.24-0.69%
NZX 50 Index13,132.5620.830.16%
S&P 5006,643.7038.980.59%
S&P/ASX 2008,862.8052.100.59%
SSE Composite Index3,862.5334.430.90%

Market Movers